ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Magnegon® 120 mg:Takeda Pharma AG
Information professionnelle complèteDDDimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
TitulaireMise à jour 
A12CC30 - Magnesium (Different Salts in Combination)ATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A12 - Mineral Supplements

This group contains mineral supplements used for treatment of mineral deficiency. All parenteral solutions of electrolytes are classified in B05B or in B05X. Magnesium carbonate used for treatment of mineral deficiency is classified in A02AA01.

A12C - Other Mineral Supplements

This group comprises other minerals.
See also B05 - Blood substitutes and perfusion solutions.

A12CC - Magnesium

Combinations with subtherapeutic amounts of vitamins are included in this group.

The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose). -

A12CC30 - Magnesium (Different Salts in Combination)
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home